Shilliday I, Allison M E
Renal Unit, Glasgow Royal Infirmary, University of Glasgow, Scotland.
Ren Fail. 1994;16(1):3-17. doi: 10.3109/08860229409044843.
Studies on the ability of loop diuretics, mannitol, dopamine, and atrial natriuretic peptide to ameliorate or reverse human acute renal failure are reviewed. A precise role for diuretic therapy in this clinical setting has not been established. Most reports are retrospective, poorly controlled, or simply anecdotal. There is a need for prospective, randomly allocated studies on adequate numbers of patients. While the use of diuretic agents may improve fluid balance management in patients at risk of developing acute renal failure, maintenance of adequate effective circulating volume and oxygen delivery probably provides the best-proven protection.
本文综述了关于袢利尿剂、甘露醇、多巴胺和心房利钠肽改善或逆转人类急性肾衰竭能力的研究。利尿剂治疗在这种临床情况下的确切作用尚未确立。大多数报告是回顾性的、控制不佳的或仅仅是轶事性的。需要对足够数量的患者进行前瞻性、随机分配的研究。虽然使用利尿剂可能改善有发生急性肾衰竭风险患者的液体平衡管理,但维持足够有效的循环血量和氧输送可能提供了最经证实的保护。